Effect of Photodynamic Therapy on Gingival Crevicular Cytokines in Periodontitis Patients
- Conditions
- Periodontitis, AdultPeriodontitisPeriodontal Attachment LossPeriodontal Pocket
- Interventions
- Device: SRP and Fotosan 630
- Registration Number
- NCT03453476
- Lead Sponsor
- National University of Singapore
- Brief Summary
Systemically healthy periodontitis patients were recruited in this single-blind, split-mouth, randomized controlled clinical trial. After SRP, PDT was applied at probing depth (PD) ≥ 4 mm at test quadrant. At baseline, 3rd month and 6th month, clinical parameters and cytokine pattern in gingival crevicular fluids (GCFs) were analysed.
- Detailed Description
Periodontal parameters and cytokine IL-1β, IL-6, IL-8, TNF-α, MMP-8 levels were analysed.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 51
- Adults who were medically fit or have medical condition that did not alter the outcome of periodontal treatment.
- Females who were not pregnant or nursing.
- Controlled diabetes mellitus with HbA1c < 7.5 mmol/L.
- Not on any antibiotics or steroids 3 months prior to periodontal treatment.
- Diagnosed to have either localized or generalized chronic or aggressive periodontitis (Armitage, 1999) with all 4 quadrants having at least 2 sites with probing depth ≥ 4 mm.
- Consented to follow the non-surgical periodontal treatment (scaling and root planing) with PDT throughout the period of study, i.e. approximately 6 months.
- Allergic to photosensitizer or dye
- Pregnant lady and nursing mothers
- Uncontrolled diabetes
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description SRP and Fotosan 630 SRP and Fotosan 630 Scaling and root planing, photodynamic therapy using Fotosan 630
- Primary Outcome Measures
Name Time Method Changes from baseline clinical attachment level at 3rd month and 6th month 3 months and 6 months Clinical attachment level in mm
Changes from baseline Interleukin-8 level at 3rd month and 6th month 3 months and 6 months Interleukin-8 level in gingival crevicular fluid
Changes from baseline Matrix metalloproteinase-8 level at 3rd month and 6th month 3 months and 6 months Matrix metalloproteinase-8 level in gingival crevicular fluid
Changes from baseline bleeding score at 3rd month and 6th month 3 months and 6 months Bleeding score in percentage
Changes from baseline Interleukin-6 level at 3rd month and 6th month 3 months and 6 months Interlekin-6 level in gingival crevicular fluid
Changes from baseline Tumour necrosis factor-alpha level at 3rd month and 6th month 3 months and 6 months Tumour necrosis factor-alpha level in gingival crevicular fluid
Changes from baseline probing depth at 3rd month and 6th month 3 months and 6 months Clinical probing depth in mm
Changes from baseline gingival recession level at 3rd month and 6th month 3 months and 6 months Gingival recession level in mm
Changes from baseline Interleukin-1 level at 3rd month and 6th month 3 months and 6 months Interleukin-1 level in gingival crevicular fluid
- Secondary Outcome Measures
Name Time Method